Amrize (AMRZ) Q1 2026 earnings review
Volume Surge in Materials Masked by Profitability Leaks
Amrize delivered 4.7% YoY revenue growth in a seasonally slow Q1, driven by an impressive double-digit volume acceleration in the Building Materials segment. However, the volume surge failed to reach the bottom line. Net Loss widened to $118 million (from $87 million a year ago) and Adjusted EBITDA contracted by 10.3%. The culprits: a sharp deceleration in the Building Envelope segment, deteriorating cement pricing, and a near-doubling of unallocated corporate costs as the company scales its standalone operations. Despite the earnings miss, management reaffirmed its bullish FY26 targets and signaled balance sheet confidence by initiating a $1.0 billion buyback and a $0.11 quarterly dividend.
🐂 Bull Case
Cement volumes jumped 13.9% and Aggregates surged 14.1%. Accelerating demand from data centers and energy infrastructure proves Amrize's end-markets are robust and capable of driving top-line growth.
Management is putting its 1.7x net leverage to work, initiating a $1.0 billion share repurchase program and a dividend. They are signaling that the worst of the spin-off transition costs are behind them.
🐻 Bear Case
Reversing its previous strength, the Building Envelope segment saw revenue drop nearly 10% and Adjusted EBITDA collapse 37.1% due to soft commercial new construction and residential weakness.
Despite management touting pricing power, actual cement pricing fell 2.4% YoY in constant currency. Combined with a spike in corporate standalone costs, overall EBITDA margins compressed by 150 basis points.
⚖️ Verdict: ⚪
Neutral. The underlying volume demand in Building Materials is genuinely impressive and supports the infrastructure macro-narrative. However, negative cement pricing, escalating corporate costs, and a struggling Building Envelope segment make the steep FY26 EBITDA guidance (+8% to +11%) look highly ambitious.
Key Themes
Infrastructure and Data Centers Fueling Volume Acceleration
Accelerating. The Building Materials segment is executing perfectly on volume. Cement tons sold rose 13.9% and aggregates rose 14.1%. Management attributes this to a robust pipeline of data centers, energy projects, and ongoing government infrastructure modernization. Approximately 50% of IIJA (Infrastructure Investment and Jobs Act) funding has been spent, leaving a long runway for continued public sector demand.
Cement Pricing Contradicts the 'Pricing Power' Narrative
Stable but Negative. Management confidently stated that U.S. cement price increases were put in place in April. However, Q1 data directly contradicts this bullishness: cement price per ton actually dropped 2.4% YoY (constant currency) to $167.67. Management blamed 'mix from a large customer project,' but if mega-projects require margin-dilutive pricing concessions, it undermines the margin expansion story for the rest of the year.
Building Envelope Segment Reversing
Decelerating. The Building Envelope segment was previously a margin darling, but Q1 results were poor. Revenue fell 9.8% to $678M, and Adjusted EBITDA plummeted 37.1% to $78M. Margins compressed massively from 16.5% to 11.5%. Management cited soft residential roofing demand, soft new commercial construction, and a 'temporary plant disruption.' They expect seasonal repair demand in H2 to offset this, but near-term momentum is broken.
ASPIRE Program and Tech-Driven Product Innovations
Stable. Amrize is heavily relying on its ASPIRE optimization program, which has already onboarded 650+ logistics and service providers to drive 70bps of targeted margin expansion in FY26. Simultaneously, the company is pushing technology and product innovations, such as the deployment of 'Elevate' advanced roofing systems to secure marquee wins like the Northwestern University sports complex, and progressing its new Malarkey Shingles plant to increase capacity by 50% in H2 2026.
Unallocated Corporate Costs Escalating
Accelerating. Unallocated corporate costs jumped 86% YoY, from $30M in 25Q1 to $56M in 26Q1. While some increase was expected as the company operates on a standalone basis (versus a carve-out basis under Holcim last year), this rapid escalation wiped out the $4M YoY growth in Total Segment Adjusted EBITDA. FY26 guidance projects $200M in corporate costs, meaning this $50M+ quarterly run-rate is the new normal and a permanent drag on consolidated margins.
Inorganic Growth Engine: PB Materials
Accelerating. Amrize completed the acquisition of PB Materials on February 18, 2026, integrating the aggregates leader in high-growth West Texas. The deal immediately contributed $24M in revenue for just the six weeks it operated under Amrize in Q1. This adds 26 operational sites and over 50 years of reserves, neatly slotting into the company's geographic expansion strategy.
Other KPIs
Decelerating. Cash burn worsened compared to the $1.06B use of cash in 25Q1. First quarters are historically highly seasonal for cash consumption due to inventory builds and annual maintenance, but the higher net loss ($31M worse YoY) and heavier capital expenditures ($272M vs $211M) deepened the cash hole. Management expects generation to normalize in H2.
Improving. A bright spot in the financials. Interest expense dropped significantly from $118M in 25Q1, reflecting the cleaner standalone capital structure post-spin-off. The weighted average interest rate sits at a manageable 5.1%, with a 6.4-year average maturity, insulating the company from immediate refinancing risks.
Guidance
Stable. The company reaffirmed its full-year topline target. Achieving the ~5% midpoint implies maintaining the 4.7% growth pace set in Q1. Given the massive infrastructure backlog and the full-year integration of PB Materials, this revenue target appears highly achievable.
Accelerating. Reaffirmed guidance requires a massive margin turnaround in the next three quarters. Because Q1 Adjusted EBITDA actually declined by 10.3%, Amrize will need to deliver roughly 12-15% EBITDA growth across Q2-Q4 to hit this target. This relies heavily on the April price increases sticking and the ASPIRE cost savings materializing fully.
Accelerating. Raised from $788M in FY25. With $272M already spent in Q1, the company is front-loading its investments in the Ste. Genevieve and Midlothian cement plant expansions, signaling confidence in multi-year demand visibility.
Key Questions
Cement Pricing Concessions
You noted that a large customer project impacted cement pricing, driving it down 2.4% YoY. Are these types of margin-dilutive pricing concessions required to win the 'mega-projects' you are highlighting as growth drivers?
Building Envelope Recovery Timeline
With commercial new construction remaining soft and a Q1 plant disruption hitting margins, how much visibility do you actually have into a second-half recovery for Building Envelope, or is the FY26 EBITDA guidance at risk?
Corporate Cost Run-Rate
Unallocated corporate costs hit $56 million this quarter. While FY26 guidance projects $200 million, are there further optimization opportunities here, or is this roughly $50 million quarterly run-rate the permanent cost of operating independently?